These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 10975012)
1. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid. Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012 [TBL] [Abstract][Full Text] [Related]
2. Shigella isolation in Vellore, south India (1997-2001). Jesudason MV Indian J Med Res; 2002 Jan; 115():11-3. PubMed ID: 12424931 [TBL] [Abstract][Full Text] [Related]
3. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014. Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468 [TBL] [Abstract][Full Text] [Related]
4. [Pathogenic surveillance and related factors on bacillary dysentery in Beijing, 2008-2017]. Jia L; Lyu B; Tian Y; Zhang X; Liu ZC; Peng H; Li HJ; Zhen BJ; Wang XL; Huang Y; Qu M; Wang QY Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Feb; 40(2):165-169. PubMed ID: 30744266 [No Abstract] [Full Text] [Related]
5. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. Cheasty T; Day M; Threlfall EJ Clin Microbiol Infect; 2004 Nov; 10(11):1033-5. PubMed ID: 15522014 [TBL] [Abstract][Full Text] [Related]
6. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy. Cheasty T; Skinner JA; Rowe B; Threlfall EJ Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania. Temu MM; Kaatano GM; Miyaye ND; Buhalata SN; Shushu ML; Kishamawe C; Changalucha JM Tanzan Health Res Bull; 2007 Sep; 9(3):186-9. PubMed ID: 18087897 [TBL] [Abstract][Full Text] [Related]
9. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783 [TBL] [Abstract][Full Text] [Related]
10. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid. Fernandez LA J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682 [No Abstract] [Full Text] [Related]
11. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009. Gu B; Cao Y; Pan S; Zhuang L; Yu R; Peng Z; Qian H; Wei Y; Zhao L; Liu G; Tong M Int J Antimicrob Agents; 2012 Jul; 40(1):9-17. PubMed ID: 22483324 [TBL] [Abstract][Full Text] [Related]
12. [Significance of determination of Shigella antibiotic resistance in bacteriological diagnosis of dysentery]. Novokshonova IV; Zelenskaia OI; Gol'dberg IE; Kozlikhin BA; Shneĭderman LV Antibiot Khimioter; 2005; 50(2-3):30-2. PubMed ID: 16308937 [TBL] [Abstract][Full Text] [Related]
13. Frequency of isolation of shigella serogroups/serotypes and their antimicrobial susceptibility pattern in children from slum areas in Karachi. Zafar A; Sabir N; Bhutta ZA J Pak Med Assoc; 2005 May; 55(5):184-8. PubMed ID: 15960281 [TBL] [Abstract][Full Text] [Related]
14. CTX-M-3 type beta-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases. Acikgoz ZC; Eser OK; Kocagöz S Jpn J Infect Dis; 2008 Mar; 61(2):135-7. PubMed ID: 18362404 [TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel. Dagan D; Orr N; Yavzori M; Yuhas Y; Meron D; Ashkenazi S; Cohen D Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):887-9. PubMed ID: 12525926 [TBL] [Abstract][Full Text] [Related]
16. Shigella isolates in stool. Pearce P; Ghuman H; Prabhakar H; Hobbs BC Indian J Pathol Microbiol; 1995 Apr; 38(2):173-5. PubMed ID: 8919104 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic resistance and molecular characterization of shigella isolates recovered from children aged less than 5 years in Manhiça, Southern Mozambique. Vubil D; Balleste-Delpierre C; Mabunda R; Acácio S; Garrine M; Nhampossa T; Alonso P; Mandomando I; Vila J Int J Antimicrob Agents; 2018 Jun; 51(6):881-887. PubMed ID: 29448013 [TBL] [Abstract][Full Text] [Related]
18. Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan. Khan E; Jabeen K; Ejaz M; Siddiqui J; Shezad MF; Zafar A J Infect Dev Ctries; 2009 Dec; 3(10):798-802. PubMed ID: 20009283 [TBL] [Abstract][Full Text] [Related]
19. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Parry CM; Ho VA; Phuong le T; Bay PV; Lanh MN; Tung le T; Tham NT; Wain J; Hien TT; Farrar JJ Antimicrob Agents Chemother; 2007 Mar; 51(3):819-25. PubMed ID: 17145784 [TBL] [Abstract][Full Text] [Related]
20. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children. Alam AN; Islam MR; Hossain MS; Mahalanabis D; Hye HK Scand J Gastroenterol; 1994 Apr; 29(4):313-7. PubMed ID: 8047805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]